Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,727 active trials51 approved drugs619 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,614 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03514849 | Clinical Study of Combined Radical Operation With Postoperative Adjuvant Chemotherapy and Prophylactic Cranial Irradiation in pT1-2N0M0 Stage of Small Cell Lung Cancer | unknown | N/A | 360 | Peng ZhangOTHER | 1 | Aug 7, 2018 | clinicaltrials |
| NCT03616691 | Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLC | unknown | Phase 2 | 46 | Samsung Medical CenterOTHER | 0 | Aug 6, 2018 | clinicaltrials |
| NCT03614065 | Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC | unknown | Phase 2 | 50 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Aug 3, 2018 | clinicaltrials |
| NCT03601598 | A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC | unknown | Phase 1 / Phase 2 | 41 | Harbin Medical UniversityOTHER | 0 | Jul 26, 2018 | clinicaltrials |
| NCT03602027 | Phase I Study of the Combination of Anlotinib With Gefitinib | unknown | N/A | 9 | Second Affiliated Hospital of Nanchang UniversityOTHER | 0 | Jul 26, 2018 | clinicaltrials |
| NCT02507518 | Role of PET Scan in the Evaluation of Early Response to Maintenance Treatment in Advanced Non-small-cell Lung Cancer(CALMETTE) | unknown | Phase 2 | 80 | Centre Henri BecquerelOTHER | 1 | Jul 23, 2018 | clinicaltrials |
| NCT03594682 | Optimizing the Therapeutic Dose of Apatinib Mesylate Tablets in Patients With Lung Cancer by Dose Titration:A Real World Exploratory Study | unknown | N/A | 31 | Beijing Chest HospitalOTHER | 0 | Jul 20, 2018 | clinicaltrials |
| NCT03396185 | Icotinib as Consolidation Therapy After Chemoradiotherapy in EGFR-Mutant Stage IIIA-IIIB Non-small Cell Lung Cancer | unknown | Phase 2 | 30 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 18, 2018 | clinicaltrials |
| NCT03589950 | Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 60 | The First People's Hospital of LianyungangOTHER | 1 | Jul 18, 2018 | clinicaltrials |
| NCT02433574 | Locally Invasive NSCLC Treated With NEo-Adjuvant Stereotactic Body RadioTherapy and REsection(LINNEARRE-I) | unknown | N/A | 20 | Juravinski Cancer CenterOTHER | 1 | Jul 17, 2018 | clinicaltrials |
| NCT03410368 | NK Cell-based Immunotherapy as Maintenance Therapy for Small-Cell Lung Cancer. | unknown | Phase 2 | 120 | jiuwei cuiOTHER | 1 | Jul 17, 2018 | clinicaltrials |
| NCT03583723 | Adaptive Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (LARTIA Trial)(LARTIA) | unknown | N/A | 50 | Campus Bio-Medico UniversityOTHER | 1 | Jul 12, 2018 | clinicaltrials |
| NCT02980536 | cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China | unknown | — | 129 | Berry Genomics Co., Ltd.INDUSTRY | 1 | Jul 11, 2018 | clinicaltrials |
| NCT02655536 | Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial(BRILLIANT) | unknown | Phase 2 | 109 | National Taiwan University HospitalOTHER | 1 | Jul 10, 2018 | clinicaltrials |
| NCT03533127 | A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer | unknown | Phase 3 | 648 | Luye Pharma Group Ltd.INDUSTRY | 1 | Jul 10, 2018 | clinicaltrials |
| NCT03581708 | Venous Thromboembolism in Advanced Lung Cancer(RIVAL) | unknown | — | 1,400 | Guangdong Provincial People's HospitalOTHER | 1 | Jul 10, 2018 | clinicaltrials |
| NCT03566576 | Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel | unknown | N/A | 18 | Fujian Cancer HospitalOTHER_GOV | 0 | Jun 25, 2018 | clinicaltrials |
| NCT03566862 | Audio Technology To Detect Lung Cancer Earlier | unknown | — | 20 | NHS Greater Glasgow and ClydeOTHER | 1 | Jun 25, 2018 | clinicaltrials |
| NCT03560362 | Postoperative Pain Control With Lipossomic Extended Release Bupivacaine | unknown | Phase 1 / Phase 2 | 50 | University of TennesseeOTHER | 1 | Jun 20, 2018 | clinicaltrials |
| NCT03546452 | A Prospective Study to Evaluate the Consistency of Next-Generation Sequencing(NGS)-Panels by Using Malignant Hydrothorax Form NSCLC | unknown | — | 50 | Shanghai Chest HospitalOTHER | 1 | Jun 7, 2018 | clinicaltrials |
| NCT02956551 | Personalized DC Vaccine for Lung Cancer(SKLB1608) | unknown | Phase 1 | 20 | Sichuan UniversityOTHER | 1 | May 31, 2018 | clinicaltrials |
| NCT03542253 | Combined Diagnosis of CT and Exosome in Early Lung Cancer | unknown | — | 80 | Second Affiliated Hospital of Soochow UniversityOTHER | 0 | May 31, 2018 | clinicaltrials |
| NCT03527251 | Anti-CTLA-4 Antibody Followed by Anti-PD-1 Antibody in Recurrent or Metastatic NSCLC(SEQUENCE) | unknown | Phase 1 | 10 | Sun Yat-sen UniversityOTHER | 1 | May 30, 2018 | clinicaltrials |
| NCT03523611 | Right Ventricular Inflammation After Lung Resection | unknown | — | 15 | University of GlasgowOTHER | 1 | May 29, 2018 | clinicaltrials |
| NCT02696525 | Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients | unknown | — | 145 | Peking University People's HospitalOTHER | 1 | May 21, 2018 | clinicaltrials |
| NCT03525782 | Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC | unknown | Phase 1 / Phase 2 | 60 | The First Affiliated Hospital of Guangdong Pharmaceutical UniversityOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT03522090 | Retrospective Comparative Study of Routine Lower Neck CT in the Staging and Diagnosis of Lung Cancer Across Two Cohorts | unknown | — | 164 | University College Hospital GalwayOTHER | 0 | May 11, 2018 | clinicaltrials |
| NCT03512015 | A Mobile Supportive Care App for Patients With Metastatic Lung Cancer(LuCApp) | unknown | N/A | 120 | Bocconi UniversityOTHER | 0 | Apr 30, 2018 | clinicaltrials |
| NCT02884479 | An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study | unknown | Phase 1 / Phase 2 | 75 | SciClone Pharmaceuticals International (Cayman) Development LimitedINDUSTRY | 1 | Apr 25, 2018 | clinicaltrials |
| NCT02134990 | Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung Cancer | unknown | Phase 2 | 20 | Oshadi Drug AdministrationINDUSTRY | 1 | Apr 18, 2018 | clinicaltrials |
| NCT01807390 | Perspectives of Receiving Open Versus Minimally Invasive Surgery(PROMIS) | unknown | — | 200 | Ottawa Hospital Research InstituteOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT03498768 | Epidemiology and Psychosocial Evaluation of Inpatient With Lung Opacity | unknown | — | 300 | Peking University People's HospitalOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT02294578 | Salivary Biomarkers for Non-small Cell Lung Cancer Detection | unknown | — | 166 | PeriRxINDUSTRY | 1 | Apr 12, 2018 | clinicaltrials |
| NCT03228056 | Postoperative Pain After Single Port, Two Ports and Three Ports VATS Lobectomy | unknown | N/A | 90 | Pulmonary Hospital ZakopaneOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT03490890 | Microwave Ablation in Ground Glass Nodules | unknown | Phase 2 | 200 | Shandong Provincial HospitalOTHER_GOV | 1 | Apr 9, 2018 | clinicaltrials |
| NCT03489616 | Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients(CRAGMOLC) | unknown | N/A | 45 | Shandong Cancer Hospital and InstituteOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| NCT03486496 | Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation(Geber) | unknown | Phase 2 | 50 | Fujian Cancer HospitalOTHER_GOV | 1 | Apr 3, 2018 | clinicaltrials |
| NCT03471884 | Effects of Nonintubated Thoracoscopic Lobectomy on Lung Protection | unknown | N/A | 82 | National Taiwan University HospitalOTHER | 1 | Mar 21, 2018 | clinicaltrials |
| NCT02758587 | Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) | unknown | Phase 1 / Phase 2 | 59 | NHS Greater Glasgow and ClydeOTHER | 1 | Mar 19, 2018 | clinicaltrials |
| NCT03464032 | A Study of BCD-135 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 30 | BiocadINDUSTRY | 1 | Mar 13, 2018 | clinicaltrials |
| NCT03460275 | Osimertinib as First-line Therapy for Patients With Late-stage Lung Cancer | unknown | Phase 2 | 100 | Sun Yat-sen UniversityOTHER | 1 | Mar 9, 2018 | clinicaltrials |
| NCT03461185 | Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer | unknown | Phase 2 | 100 | Xinqiao Hospital of ChongqingOTHER | 1 | Mar 9, 2018 | clinicaltrials |
| NCT02778854 | Liquid Biopsy for Detection of Driver Mutation in NSCLC | unknown | — | 200 | Chinese PLA General HospitalOTHER | 1 | Mar 8, 2018 | clinicaltrials |
| NCT03453307 | Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients | unknown | — | 100 | K2 Oncology, Inc.INDUSTRY | 1 | Mar 5, 2018 | clinicaltrials |
| NCT01102517 | A Trial on Video-assisted Thoracoscopic Surgery and Axillary Thoracotomy for Resection of Early-stage Non-small Cell Lung Cancer | unknown | N/A | 500 | Sun Yat-sen UniversityOTHER | 1 | Feb 28, 2018 | clinicaltrials |
| NCT03384667 | Maekmoondong-tang on Post-operative Cough in Patients With Lung Cancer | unknown | Phase 2 / Phase 3 | 96 | Seong-Gyu KoOTHER | 1 | Feb 28, 2018 | clinicaltrials |
| NCT03076372 | A Study Evaluating MM-310 in Patients With Solid Tumors | unknown | Phase 1 | 34 | Merrimack PharmaceuticalsINDUSTRY | 1 | Feb 27, 2018 | clinicaltrials |
| NCT03446911 | Combining SBRT and Immunotherapy in Early Stage NSCLC Patients Planned for Surgery | unknown | Phase 1 / Phase 2 | 20 | Amsterdam UMC, location VUmcOTHER | 0 | Feb 27, 2018 | clinicaltrials |
| NCT03432637 | Clinical Trial of Thoracoscopic Lobecotmy Under Spontaneous Ventilating Anesthesia | unknown | Phase 3 | 450 | Guangzhou Institute of Respiratory DiseaseOTHER | 1 | Feb 26, 2018 | clinicaltrials |
Data updated 24 days agoSource updated Aug 7, 2018source: clinicaltrials